Allergen, Individual-Drug Nimesulide pain killer

This at‑home allergy evaluation assesses immune sensitivity specifically to nimesulide, a non‑steroidal analgesic. The service typically uses laboratory assays—such as drug‑specific IgE measurement and cellular activation tests—on a venous blood sample collected at your Dubai address and analysed in an accredited UAE laboratory to support clinical decision‑making.

The test is intended for people who have experienced suspected immediate or delayed reactions after taking nimesulide, or for patients with a history of drug allergies where a safer analgesic choice is required. Results and a clinician‑oriented report help your doctor weigh alternatives, reduce the risk of repeat hypersensitivity, and plan any further specialist evaluation such as skin testing or supervised drug challenge.

Turnaround is rapid through accredited labs (typically communicated within 48–72 hours, depending on test panel), and results should be interpreted alongside clinical history by a qualified physician or allergist. A negative laboratory result does not completely exclude drug hypersensitivity—additional testing or specialist referral may be advised for definitive diagnosis.

• Nimesulide‑specific IgE
• Drug‑specific IgG
• Basophil Activation Test (CD63/CD203c)
• Lymphocyte Transformation Test (LTT) for delayed reactions
• Total IgE

• After any suspected allergic reaction to nimesulide (rash, urticaria, angioedema, anaphylaxis)
• Unexplained cutaneous or systemic reaction following NSAID or analgesic use
• Prior to prescribing nimesulide in patients with a history of drug allergy
• To guide selection of alternative painkillers when nimesulide sensitivity is suspected
• When an allergist recommends laboratory confirmation before skin testing or drug challenge

• Identification of immune sensitivity specifically to nimesulide
• At‑home venous sample collection in Dubai by trained phlebotomists
• Fast analysis and reporting from accredited UAE laboratories
• Actionable results to help clinicians choose safer analgesic alternatives
• Reduced risk of repeat or severe hypersensitivity through informed prescribing

• At‑home venous blood collection by a certified phlebotomist (Dubai service area)
• No fasting required prior to sample collection
• If possible, avoid antihistamines for 48–72 hours and inform us of corticosteroid or immunosuppressant use (consult your physician before stopping any medication)
• Provide detailed medication and allergy history; pediatric collection available on request